NCT06029309
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- University of Miami Miami, Florida, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,774 public trials
698 recruiting studies
Lymphoma, Non-Hodgkin trial results
Recruiting
Orelabrutinib Combined With Zebetuzumab and Lenalidomide for the Treatment of Newly Diagnosed MZL
NCT07208981
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital Nanjing, Jiangsu, China
NCT06534060
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University of San Diego (UCSD)-Moores Cancer Center San Diego, California, United States
- SCRI - Colorado Blood Cancer Institute (CBCI) Denver, Colorado, United States
- Moffitt Cancer Center Magnolia Campus Tampa, Florida, United States
- University of Iowa Iowa City, Iowa, United States
Recruiting
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
NCT05296070
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of Miami Miami, Florida, United States
- Emory University Atlanta, Georgia, United States
- Vanderbilt University Nashville, Tennessee, United States
NCT07199296
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ruijin Hospital Shanghai, China
NCT07189806
- Conditions
- Asthma, Asthma (Diagnosis), Bronchial Diseases, +26 more
- Locations
-
- hVIVO Services Limited, 40 Bank Street London, United Kingdom
NCT06453044
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
NCT05326308
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
- Locations
-
- Universitätsklinikum Salzburg, Klinik für Innere Medizin III Salzburg, Austria
- Lübecker Onkologische Schwerpunktpraxis Lübeck, Schleswig-Holstein, Germany
NCT04993690
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
NCT04234048
- Conditions
- Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, +23 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- City of Hope Medical Foundation Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States